Treatment of vitamin D deficiency in transfusion-dependent thalassemia

American Journal of Hematology

Volumn 86, Issue 10, 2011, Pages 871-873

  Fung, Ellen B ^a   Aguilar, Catherine ^a   Micaily, Ida ^a   Haines, Drucilla ^a   Lal, Ashutosh ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOCALCIFEROL; VITAMIN D;

ADULT; BLOOD SAMPLING; CHEMOLUMINESCENCE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THALASSEMIA; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; THALASSEMIA; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 80052905292     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22117     Document Type: Letter

References (16)

1. Vogiatzi MG, Macklin EA, Fung EB, et al. Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res 2009; 24: 543-557.
2. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium: A systematic review of health outcomes. Evidence Report No. 183. AHRQ Publication No. 09-E105. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
3. Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol 2009; 146: 546-556.
4. Dimitriadou M, Christoforidis A, Economou M, et al. Elevated serum parathormone levels are associated with myocardial iron overload in patients with β-thalassaemia major. Eur J Haematol 2010; 84: 64-71.
5. Shamshirsaz A, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: A multicenter study in Tehran. BMC Endocr Disord 2003; 3: 4.
6. Tantawy AA, El Kholy M, Moustafa T, et al. Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 2008; 6 (Suppl 1): 132-135.
7. Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, et al. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res 2003; 18: 1682-1688.
8. Napoli N, Carmina E, Bucchieri S, et al. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 2006; 38: 888-892.
9. Zamboni G, Marradi P, Tagliaro F, et al. Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major. Eur J Pediatr 1986; 145: 133-136.
10. Moulas A, Challa A, Chaliasos N, et al. Vitamin D metabolites (25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1, 25-dihydroxyvitamin D) and osteocalcin in B-thalassaemia. Acta Paediatr 1997; 86: 594-599.
11. Tangpricha V, Pearce EN, Chen TC, et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002; 112: 659-662.
12. Soliman A, Adel A, Wagdy M, et al. Calcium homeostasis in 40 adolescents with beta-thalassemia major: A case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev 2008; 6 (Suppl 1): 149-154.
13. IOM (Institute of Medicine). Dietary Reference Intakes for and Vitamin D. Washington, DC: The National Academies Press; 2011.
14. Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol 2008; 141: 891-894.
15. Soliman AT, Adel A, Wagdy M, et al. Manifestations of severe vitamin D deficiency in adolescents: Effects of intramuscular injection of a megadose of cholecalciferol. J Trop Pediatr, in press.
16. 3 in humans. J Clin Endocrinol Metab 2004; 89: 5387-5391.